Karma Biotechnologies

Closed

Los Angeles, United States · Founded 2017

Headquarters
Los Angeles
Founded
2017
Last Round
SeedOct 2023
Rounds
1

About

Karma Biotechnologies is an oncology startup developing lipid nanoparticle (LNP) systems for localized delivery of DNA and RNA payloads to solid tumors, initially targeting colorectal cancer and other hard-to-penetrate tumors. The company's proprietary LNPs deliver DNA and RNA payloads without electroporation and can transfect macrophages that home to tumor sites, localizing biologics such as IL-15 to convert cold tumors into more immunologically active ones. Karma was an SOSV/IndieBio portfolio company.

Summary

Karma Biotechnologies is a Biotech company based in Los Angeles, United States, founded in 2017. Its most recent funding was a Seed round in Oct 2023. Investors include SOSV, IndieBio and Tuesday Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundOct 2023

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Karma Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/karma-biotechnologies"><img src="https://indexed.vc/api/badge/company/karma-biotechnologies" alt="Karma Biotechnologies on Indexed.vc" width="260" height="76" /></a>